Lucent Diagnostics, a brand of Quanterix (QTRX) Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of ...

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in asymptomatic patients.

BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect ...

Share on Pinterest Blood tests may help detect some neurodegenerative diseases in the future. Patricio Nahuelhual/Getty Images Researchers have discovered a blood marker they say can help in ...

A combined blood test for cognitive decline has a 90% accuracy rate in determining whether memory loss is due to Alzheimer’s disease. Dr. Sanjay Gupta explains. When Penny Ashford’s father was ...

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

These markers are most helpful when someone already has a diagnosed cancer — to track treatment response or detect recurrence ...

Please provide your email address to receive an email when new articles are posted on . Biomarker combinations improved detection of pancreatic cancer in a double-blind trial. A phase 3 investigation ...

A new three-pronged blood test can highlight people with a nearly tripled risk for heart attack, a new study says. The test relies on three blood markers linked to heart disease: lipoprotein a [Lp(a)] ...

Since researchers first established the link between diet, cholesterol and heart disease in the 1950s, risk for heart disease ...

BNP may help doctors identify HCM patients at highest risk of serious heart complications, improving monitoring and treatment ...

Scientists develop new blood test to identify individuals at high risk of developing hypertrophic cardiomyopathy, most common ...